Clinical Trial Update: Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of dinutuximab beta as maintenance therapy in Chinese participants with high-risk neuroblastoma; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• dinutuximab beta (dinutuximab beta)

Snippet

Sponsor: BeiGene | Conditions: High-risk Neuroblastoma | Phase 1 | Status: COMPLETED | Results posted: 2024-10-04